Global Information
회사소개 | 문의 | 비교리스트

세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 서비스별, 기업 규모별, 카테고리별, 적응증별, 단계별, 최종사용자별, 지역별 시장 규모와 예측(2022-2028년)

Global Regulatory Affairs Outsourcing Market Size study, by Services by Company Size by Category by Indication by Stage (Preclinical, Clinical, PMA ) by End-use and Regional Forecasts 2022-2028

리서치사 Bizwit Research & Consulting LLP
발행일 2022년 06월 상품코드 1090079
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,950 ₩ 7,031,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 8,878,000 Printable PDF (Enterprise License)


세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 서비스별, 기업 규모별, 카테고리별, 적응증별, 단계별, 최종사용자별, 지역별 시장 규모와 예측(2022-2028년) Global Regulatory Affairs Outsourcing Market Size study, by Services by Company Size by Category by Indication by Stage (Preclinical, Clinical, PMA ) by End-use and Regional Forecasts 2022-2028
발행일 : 2022년 06월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 RA(Regulatory Affairs) 아웃소싱 시장 규모는 2021년에 약 57억 2,000만 달러를 기록했으며, 2022-2028년 예측기간 중 8.90% 이상의 건전한 성장률로 성장할 것으로 예상됩니다.

시장을 견인하고 있는 것은 연구개발 활동 활발화에 의한 임상시험 신청 건수와 제품 등록 건수 증가입니다. 또한 생물제제 증가, 혁신적인 기술에 대한 높은 수요, 개별화된 희귀질환용 의약품·의학의 요구 등이 예측기간 중 성장을 촉진할 것으로 예상됩니다. 그러나 2022-2028년 예측기간에는 다양한 의료 품목을 관리하는 정부의 엄격한 규제가 시장 성장을 억제할 것으로 예상됩니다.

세계의 RA(Regulatory Affairs) 아웃소싱 시장에 대해 조사 분석했으며, 시장 동향, 업계 분석, COVID-19의 영향, 부문별·지역별 시장 분석, 기업 개요 등을 제공합니다.

목차

제1장 주요 요약

제2장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 정의와 범위

제3장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 역학

  • RA(Regulatory Affairs) 아웃소싱 시장의 영향 분석(2020-2028년)

제4장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 업계 분석

  • Porter's 5 Force 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 추천사항과 결론
  • 주요 투자 기회
  • 주요 성공 전략

제5장 위험 평가 : COVID-19의 영향

    • 업계에 대한 COVID-19의 전체적인 영향 평가
    • COVID-19 이전·COVID-19 이후 시장 시나리오

제6장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 서비스별

  • 시장 현황
  • 실적·잠재성 분석 : 서비스별
  • 추정과 예측 : 서비스별(2018-2028년)
  • 하위 부문 분석
    • 규제 컨설팅
    • 법정 대리인
    • 규제 문서 작성과 공개
    • 제품 등록과 임상시험 신청
    • 기타 서비스

제7장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 기업 규모별

  • 시장 현황
  • 실적·잠재성 분석 : 기업 규모별
  • 추정과 예측 : 기업 규모별(2018-2028년)
  • 하위 부문 분석
    • 소규모
    • 중규모
    • 대규모

제8장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 카테고리별

  • 시장 현황
  • 실적·잠재성 분석 : 카테고리별
  • 추정과 예측 : 카테고리별(2018-2028년)
  • 하위 부문 분석
    • 의약품
    • 제네릭
    • 이노베이터
    • 생물제제
    • 바이오테크놀러지
    • ATMP
    • 바이오시밀러
    • 의료기기
    • 치료
    • 진단

제9장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 적응증별

  • 시장 현황
  • 실적·잠재성 분석 : 적응증별
  • 추정과 예측 : 적응증별(2018-2028년)
  • 하위 부문 분석
    • 종양학
    • 신경학
    • 심장병학
    • 면역학
    • 기타

제10장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 단계별

  • 시장 현황
  • 실적·잠재성 분석 : 단계별
  • 추정과 예측 : 단계별(2018-2028년)
  • 하위 부문 분석
    • 전임상
    • 임상
    • PMA(Post Market Authorization)

제11장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 최종 용도별

  • 시장 현황
  • 실적·잠재성 분석 : 최종 용도별
  • 추정과 예측 : 최종 용도별(2018-2028년)
  • 하위 부문 분석
    • 의료기기 기업
    • 제약 기업
    • 바이오테크놀러지 기업

제12장 세계의 RA(Regulatory Affairs) 아웃소싱 시장 : 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽 현황
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양 현황
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카 현황
    • 브라질
    • 멕시코
  • 기타 지역

제13장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Accell Clinical Research, LLC
    • GenPact Ltd.
    • Criterium, Inc.
    • PRA Health Sciences
    • Promedica International
    • Dr. Regenold GmbH
    • BioMapas
    • Zeincro Group
    • Parexel International Corp.
    • Charles River Laboratories International, Inc.

제14장 조사 과정

KSM 22.06.29

LIST OF TABLES

  • TABLE 1. Global Regulatory Affairs Outsourcing Market, report scope
  • TABLE 2. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Services 2018-2028 (USD Billion)
  • TABLE 4. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Company Size 2018-2028 (USD Billion)
  • TABLE 5. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Category 2018-2028 (USD Billion)
  • TABLE 6. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Indication 2018-2028 (USD Billion)
  • TABLE 7. Global Regulatory Affairs Outsourcing Market estimates & forecasts by Stage 2018-2028 (USD Billion)
  • TABLE 8. Global Regulatory Affairs Outsourcing Market estimates & forecasts by End-use 2018-2028 (USD Billion)
  • TABLE 9. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. Global Regulatory Affairs Outsourcing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 18. Global Regulatory Affairs Outsourcing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 19. U.S. Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. U.S. Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. U.S. Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. Canada Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. Canada Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. Canada Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. UK Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. UK Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. UK Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. Germany Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. Germany Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. Germany Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. RoE Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. RoE Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. RoE Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. China Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. China Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. China Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. India Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. India Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. India Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. Japan Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. Japan Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. Japan Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. RoAPAC Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. RoAPAC Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. RoAPAC Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Brazil Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Brazil Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Brazil Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. Mexico Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. Mexico Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. Mexico Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. RoLA Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. RoLA Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. RoLA Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. Row Regulatory Affairs Outsourcing Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 56. Row Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 57. Row Regulatory Affairs Outsourcing Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 58. List of secondary sources, used in the study of global Regulatory Affairs Outsourcing Market
  • TABLE 59. List of primary sources, used in the study of global Regulatory Affairs Outsourcing Market
  • TABLE 60. Years considered for the study
  • TABLE 61. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Regulatory Affairs Outsourcing Market, research methodology
  • FIG 2. Global Regulatory Affairs Outsourcing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Regulatory Affairs Outsourcing Market, key trends 2021
  • FIG 5. Global Regulatory Affairs Outsourcing Market, growth prospects 2022-2028
  • FIG 6. Global Regulatory Affairs Outsourcing Market, porters 5 force model
  • FIG 7. Global Regulatory Affairs Outsourcing Market, pest analysis
  • FIG 8. Global Regulatory Affairs Outsourcing Market, value chain analysis
  • FIG 9. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Regulatory Affairs Outsourcing Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Regulatory Affairs Outsourcing Market, regional snapshot 2018 & 2028
  • FIG 15. North America Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Regulatory Affairs Outsourcing Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Regulatory Affairs Outsourcing Market, company Market share analysis (2021)

Global Regulatory Affairs Outsourcing Market is valued approximately USD 5.72 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.90 % over the forecast period 2022-2028. Regulatory affairs outsourcing is becoming more common in the healthcare industry. The adoption of regulatory outsourcing models is projected to be aided by an increase in geographical expansion activities by corporations seeking quick approvals in local markets. The regulatory affairs outsourcing market is quickly growing as a result of increased R&D activity, which is increasing the number of clinical trial applications and product registrations. Outsourcing of regulatory affairs duties is being driven by a significant increase in the fixed expenses of in-house resources for regulatory affairs and operations activities such as training, technology, specialist knowledge, and facilities. For example, ProPharma Group bought iSafety Systems, an Indian pharmacovigilance service provider, in August 2021 to boost its pharmacovigilance market position. Similarly, in July 2021, ICON plc purchased PRA Health Sciences, contract research organization that specializes in medication development and regulatory consultation. The goal of this acquisition was to expand ICON plc's service portfolio. The demand for these services is being driven by local legal challenges and frequent changes in the rules of major markets such as the United States, Europe, and Asia.. Amendments to current regulations are likely to make the regulatory process easier for the business, but they will also make it more difficult for healthcare product manufacturers to operate. As a result, regulatory affairs are being outsourced to service providers. This is due to an increase in the number of clinical trial registrations in recent years. ClinicalTrials.gov reports that about 401,716 studies were registered in January 2022, up from around 325,834 by the end of 2019. Furthermore, an increase in the number of biologics, a high demand for innovative technologies, and a need for individualized orphan pharmaceuticals and medicine are all expected to drive segment growth throughout the projection period. However, over the projection period of 2022-2028, rigorous government regulations governing various medical items would stifle market growth.

The key regions considered for the global Regulatory Affairs Outsourcing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The Asia Pacific area had the largest share. Over the forecast period, the area is also expected to have the quickest CAGR. This can be linked to an increase in clinical trials as well as a rise in the number of enterprises attempting to penetrate developing markets such as India and China. Another element projected to drive regional market expansion is the availability of a competent labour in the region at cheaper costs than in the United States.

Major market player included in this report are:

Accell Clinical Research, LLC

GenPact Ltd.

Criterium, Inc.

PRA Health Sciences

Promedica International

Dr. Regenold GmbH

BioMapas

Zeincro Group

Parexel International Corp.

Charles River Laboratories International, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Services

Regulatory Consulting

Legal Representation

Regulatory Writing & Publishing

Product Registration & Clinical Trial Applications

Other Services

By Company Size

Small

Medium

Large

By Category

Drugs

Generics

Innovators

Biologics

Biotech

ATMPs

Biosimilars

Medical devices

Therapeutic

Diagnostic

By Indication

Oncology

Neurology

Cardiology

Immunology

Others

By Stage

Preclinical

Clinical

PMA (Post Market Authorization)

By End-use

Medical Device Companies

Pharmaceutical Companies

Biotechnology Companies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Regulatory Affairs Outsourcing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Regulatory Affairs Outsourcing Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Regulatory Affairs Outsourcing Market, by Services, 2020-2028 (USD Billion)
    • 1.2.3. Regulatory Affairs Outsourcing Market, by Company Size, 2020-2028 (USD Billion)
    • 1.2.4. Regulatory Affairs Outsourcing Market, by Category, 2020-2028 (USD Billion)
    • 1.2.5. Regulatory Affairs Outsourcing Market, by Indication, 2020-2028 (USD Billion)
    • 1.2.6. Regulatory Affairs Outsourcing Market, by Stage, 2020-2028 (USD Billion)
    • 1.2.7. Regulatory Affairs Outsourcing Market, by End-use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Regulatory Affairs Outsourcing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Regulatory Affairs Outsourcing Market Dynamics

  • 3.1. Regulatory Affairs Outsourcing Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Significant increase in the fixed costs of in-house resources for regulatory affairs & operation activities
      • 3.1.1.2. Augmenting the volume of clinical trial applications and product registration
    • 3.1.2. Market Challenges
      • 3.1.2.1. Strict government regulations regarding the various medical products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in geographical expansion activities by companies
      • 3.1.3.2. Increase in R&D activities

Chapter 4. Global Regulatory Affairs Outsourcing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Regulatory Affairs Outsourcing Market, by Services

  • 6.1. Market Snapshot
  • 6.2. Global Regulatory Affairs Outsourcing Market by Services, Performance - Potential Analysis
  • 6.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Services 2018-2028 (USD Billion)
  • 6.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 6.4.1. Regulatory Consulting
    • 6.4.2. Legal Representation
    • 6.4.3. Regulatory Writing & Publishing
    • 6.4.4. Product Registration & Clinical Trial Applications
    • 6.4.5. Other Services

Chapter 7. Global Regulatory Affairs Outsourcing Market, by Company Size

  • 7.1. Market Snapshot
  • 7.2. Global Regulatory Affairs Outsourcing Market by Company Size, Performance - Potential Analysis
  • 7.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Company Size 2018-2028 (USD Billion)
  • 7.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 7.4.1. Small
    • 7.4.2. Medium
    • 7.4.3. Large

Chapter 8. Global Regulatory Affairs Outsourcing Market, by Category

  • 8.1. Market Snapshot
  • 8.2. Global Regulatory Affairs Outsourcing Market by Category, Performance - Potential Analysis
  • 8.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Category 2018-2028 (USD Billion)
  • 8.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 8.4.1. Drugs
    • 8.4.2. Generics
    • 8.4.3. Innovators
    • 8.4.4. Biologics
    • 8.4.5. Biotech
    • 8.4.6. ATMPs
    • 8.4.7. Biosimilars
    • 8.4.8. Medical devices
    • 8.4.9. Therapeutic
    • 8.4.10. Diagnostic

Chapter 9. Global Regulatory Affairs Outsourcing Market, by Indication

  • 9.1. Market Snapshot
  • 9.2. Global Regulatory Affairs Outsourcing Market by Indication, Performance - Potential Analysis
  • 9.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)
  • 9.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 9.4.1. Oncology
    • 9.4.2. Neurology
    • 9.4.3. Cardiology
    • 9.4.4. Immunology
    • 9.4.5. Others

Chapter 10. Global Regulatory Affairs Outsourcing Market, by Stage

  • 10.1. Market Snapshot
  • 10.2. Global Regulatory Affairs Outsourcing Market by Stage, Performance - Potential Analysis
  • 10.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by Stage 2018-2028 (USD Billion)
  • 10.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 10.4.1. Preclinical
    • 10.4.2. Clinical
    • 10.4.3. PMA (Post Market Authorization)

Chapter 11. Global Regulatory Affairs Outsourcing Market, by End-use

  • 11.1. Market Snapshot
  • 11.2. Global Regulatory Affairs Outsourcing Market by End-use, Performance - Potential Analysis
  • 11.3. Global Regulatory Affairs Outsourcing Market Estimates & Forecasts by End-use 2018-2028 (USD Billion)
  • 11.4. Regulatory Affairs Outsourcing Market, Sub Segment Analysis
    • 11.4.1. Medical Device Companies
    • 11.4.2. Pharmaceutical Companies
    • 11.4.3. Biotechnology Companies

Chapter 12. Global Regulatory Affairs Outsourcing Market, Regional Analysis

  • 12.1. Regulatory Affairs Outsourcing Market, Regional Market Snapshot
  • 12.2. North America Regulatory Affairs Outsourcing Market
    • 12.2.1. U.S. Regulatory Affairs Outsourcing Market
      • 12.2.1.1. Services breakdown estimates & forecasts, 2018-2028
      • 12.2.1.2. Company Size breakdown estimates & forecasts, 2018-2028
      • 12.2.1.3. Category breakdown estimates & forecasts, 2018-2028
      • 12.2.1.4. Indication breakdown estimates & forecasts, 2018-2028
      • 12.2.1.5. Stage breakdown estimates & forecasts, 2018-2028
      • 12.2.1.6. End-use breakdown estimates & forecasts, 2018-2028
    • 12.2.2. Canada Regulatory Affairs Outsourcing Market
  • 12.3. Europe Regulatory Affairs Outsourcing Market Snapshot
    • 12.3.1. U.K. Regulatory Affairs Outsourcing Market
    • 12.3.2. Germany Regulatory Affairs Outsourcing Market
    • 12.3.3. France Regulatory Affairs Outsourcing Market
    • 12.3.4. Spain Regulatory Affairs Outsourcing Market
    • 12.3.5. Italy Regulatory Affairs Outsourcing Market
    • 12.3.6. Rest of Europe Regulatory Affairs Outsourcing Market
  • 12.4. Asia-Pacific Regulatory Affairs Outsourcing Market Snapshot
    • 12.4.1. China Regulatory Affairs Outsourcing Market
    • 12.4.2. India Regulatory Affairs Outsourcing Market
    • 12.4.3. Japan Regulatory Affairs Outsourcing Market
    • 12.4.4. Australia Regulatory Affairs Outsourcing Market
    • 12.4.5. South Korea Regulatory Affairs Outsourcing Market
    • 12.4.6. Rest of Asia Pacific Regulatory Affairs Outsourcing Market
  • 12.5. Latin America Regulatory Affairs Outsourcing Market Snapshot
    • 12.5.1. Brazil Regulatory Affairs Outsourcing Market
    • 12.5.2. Mexico Regulatory Affairs Outsourcing Market
  • 12.6. Rest of The World Regulatory Affairs Outsourcing Market

Chapter 13. Competitive Intelligence

  • 13.1. Top Market Strategies
  • 13.2. Company Profiles
    • 13.2.1. Accell Clinical Research, LLC
      • 13.2.1.1. Key Information
      • 13.2.1.2. Overview
      • 13.2.1.3. Financial (Subject to Data Availability)
      • 13.2.1.4. Company Size Summary
      • 13.2.1.5. Recent Developments
    • 13.2.2. GenPact Ltd.
    • 13.2.3. Criterium, Inc.
    • 13.2.4. PRA Health Sciences
    • 13.2.5. Promedica International
    • 13.2.6. Dr. Regenold GmbH
    • 13.2.7. BioMapas
    • 13.2.8. Zeincro Group
    • 13.2.9. Parexel International Corp.
    • 13.2.10. Charles River Laboratories International, Inc.

Chapter 14. Research Process

  • 14.1. Research Process
    • 14.1.1. Data Mining
    • 14.1.2. Analysis
    • 14.1.3. Market Estimation
    • 14.1.4. Validation
    • 14.1.5. Publishing
  • 14.2. Research Attributes
  • 14.3. Research Assumption
Back to Top
전화 문의
F A Q